1. Brandes AA, Pasetto LM, Monfardini S (2000) New drugs in recurrent high grade gliomas. Anticancer Res 20:1913
2. Prados MD (2000) Future directions in the treatment of malignant gliomas with temozolomide. Semin Oncol 27:41
3. Baker SD, Wirth M, Statkevich P, Reidenberg P, Alton K, Sartorius SE, Dugan M, Cutler D, Batra V, Grochow LB, Donehower RC, Rowinsky EK (1999) Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res 5:309
4. Newlands ES, Blackledge GRP, Slack JA, Rustin GJS, Smith DB, Stuart NSA, Quarterman CP, Hofman R, Stevens MFG, Brampton MH, Gibson AC (1992) Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 65:287
5. Reid JM, Stevens DC, Rubin J, Ames MM (1997) Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following the administration of temozolomide to patients with advanced cancer. Clin Cancer Res 3:2393